文献速递中医内科中药与中成药合理使用针灸推拿

中药与西药联合治疗溃疡性结肠炎的系统评价与网状Meta分析

Systematic review and network meta-analysis of integrated traditional Chinese and conventional medicine for ulcerative colitis.
PubMed 文献 · Front Pharmacol · 2026-06-25

该系统评价与网状Meta分析纳入46项RCT共3763例UC患者,比较中药、西药及中西医结合治疗。结果显示西药联合中药汤剂及穴位埋线总有效率最高,单用西药在缓解腹泻腹痛及降低IL-8、CRP、ESR方面排名最高;但临床评分改善及内镜黏膜愈合证据不足。

要点

  • 西药联合中药汤剂及穴位埋线总有效率最高。
  • 单用西药在缓解腹泻腹痛及降低IL-8、CRP、ESR排名最高。
  • 临床评分改善及内镜黏膜愈合证据仍不足。

核心结论

  • 与单用西药相比,中西医结合治疗UC总体疗效更优。
  • 网状Meta分析针对不同结局指标识别了最优干预方案,包括单用与联合治疗。
  • 中药可改善临床症状和炎症生物标志物,但临床评分改善和内镜黏膜愈合证据不足。

研究设计与样本

  • 系统评价与网状Meta分析,纳入46项RCT共3763例UC患者。
  • 检索PubMed、Embase、Web of Science、CNKI、万方、维普和SinoMed,截至2025年6月。
  • 采用Review Manager 5.4和7分Jadad量表评估质量,Stata MP 15和R 4.3.1分析。

主要发现

  • 共纳入七种干预方案,包括四种中成药(如云南白药)和十六种经典中药汤剂(如白头翁汤)。
  • 西药联合中药汤剂及穴位埋线总有效率最高。
  • 单用西药在缓解腹泻腹痛及降低IL-8、CRP、ESR方面排名最高。
  • 西药联合中药汤剂及针刺降低IL-6排名最高,西药联合中药汤剂改善IL-10排名最高,单用西药在这两项排名较低。

关键数值与推荐

  • 纳入46项RCT共3763例UC患者,干预方案含四种中成药和十六种经典中药汤剂。

临床怎么用

  • 临床可根据患者个体情况选择最优方案。
  • 中西医结合治疗UC总体疗效优于单用西药。
  • 中药干预可改善临床症状和炎症生物标志物,但需注意临床评分和内镜愈合证据不足。

局限性

  • 临床评分改善及内镜黏膜愈合证据仍不足。
  • 仍需进一步高质量临床证据确认中药的明确临床疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To optimize clinical management of ulcerative colitis (UC) and evaluate the efficacy of traditional Chinese medicine (TCM), conventional medicine (CM), and integrated TCM- CM therapies. METHODS: Randomized controlled trials (RCTs) investigating integrated TCM-CM treatment for UC were retrieved from PubMed, Embase, Web of Science, CNKI, Wanfang Data, VIP Database, and SinoMed from database inception to June 2025. Study quality was assessed using Review Manager 5.4 and the 7-point Jadad scale. Statistical analyses were performed using Stata MP 15 and R 4.3.1 with Rstudio. RESULTS: A total of 46 RCTs involving 3,763 patients with UC were included, comprising seven intervention regimens: four commercial Chinese polyherbal preparation (e.g., Yunnan Baiyao) and sixteen classical TCM decoctions (TCMDs; e.g., Baitouweng Decoction). The results showed that conventional medicine combined with TCMD and acupoint catgut embedding achieved the highest total effective rate. CM alone ranked highest in alleviating key clinical symptoms (e.g., diarrhea and abdominal pain) and in reducing inflammatory markers, including IL-8, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). For cytokine regulation, comparative advantages varied across interventions: CM + TCMD + acupuncture ranked highest for IL-6 reduction, CM + TCMD ranked highest for IL-10 improvement, whereas CM alone ranked lower for these two outcomes. CONCLUSION: Compared with the single use of conventinal medicine, the combined use of traditional Chinese and conventinal medicine in the treatment of ulcerative colitis demonstrates greater overall efficacy. Through network meta-analysis, this study identified optimal intervention regimens for different outcome indicators, including both monotherapy and combination therapy. In clinical practice, the optimal regimens may be selected according to individual patient conditions. Although TCM interventions can improve clinical symptoms and inflammatory biomarkers in patients with ulcerative colitis, relevant clinical score improvement and endoscopic mucosal healing evidence are still insufficient. Further high-quality clinical evidence is still required to confirm the definite clinical efficacy of TCM. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=1109183, identifier CRD420251109183.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li X, Sha Z. Systematic review and network meta-analysis of integrated traditional Chinese and conventional medicine for ulcerative colitis. Front Pharmacol. 2026. PMID: 42428503. doi:10.3389/fphar.2026.1785134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。